Lv11
14 积分 2024-06-27 加入
A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic Cancer
5小时前
待确认
Targeting DNA Repair with Combined Inhibition of NHEJ and MMEJ Induces Synthetic Lethality in TP53-Mutant Cancers
5小时前
已完结
Efficacy and safety of phosphoinositide 3-kinase inhibitors and AKT-inhibitors in combination with fulvestrant in PIK3CA mutated, HR-positive, HER2-negative invasive breast cancer: A systematic review
4天前
已完结
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
14天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
18天前
已完结
CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress
29天前
已完结
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
29天前
已完结
Inhibition of Chk1 by Activated PKB/Akt
29天前
已完结
Bevacizumab induces inflammation in MDA-MB-231 breast cancer cell line and in a mouse model
1个月前
已完结
Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival
1个月前
已关闭
皖公网安备34019202002308
